Chronic pain will be treated with CBD by SUS – 06/15/2023 – Cannabis Inc.
[ad_1]
Chronic pain enters the list of conditions that can be treated with cannabis medicine in the SUS (Sistema Único de Saúde) in São Paulo. The decision was taken last Tuesday (13th), during a meeting of the Work Committee, made up of 32 bodies, including non-profit entities supporting research, as is the case of the Faculty of Medicine of USP (University of São Paulo), technicians and patient associations, such as Cultive. The group aims to develop proposals for the implementation of the policy across the state to adapt the therapy to the public health model.
This is the fourth health condition approved by the commission. The other three were announced at the beginning of the month: multiple sclerosis, Dravet and Lennox-Gastaut Syndrome. “At all the meetings I defended the autonomy of doctors in prescribing”, wrote on Instagram deputy Caio França (PSB), one of the members of the commission and author of law n°17.618/2023, which authorizes the free distribution of CBD, sanctioned in January.
Although the prescription is always the doctor’s prerogative, it was up to the group to analyze the diseases that will be included in the SUS list for treatment with cannabis medicinal. There is a likelihood of including other conditions. But that depends on the analysis of clinical studies proving the drug’s action. Refractory epilepsy and autism are priorities.
This methodology divides opinions. “The Government is using a good strategy to define the public policy of free distribution”, said José Bacellar, CEO of Verdemed, which has CBD products approved by Anvisa (Health Surveillance Agency). Among the arguments that support this position is the high cost of the drug and the impact it would have on the public health system if there were no restriction on prescription.
Doctors are concerned about the universal accessibility of the product, which the SUS should guarantee. “The State opted for very rare diseases”, said psychiatrist Eliane Nunes, director of SBEC (Brazilian Society for the Study of Cannabis). “Many patients will continue to be unable to be treated with CBD, as it is a high-cost therapy” They will remain dependent on outputs such as lawsuits or import and planting injunctions, which are also very costly for the State.
The bodies and entities that participate in the Working Committee:
- Office of the Secretary and Advisers
- Group for the Coordination of Strategic Demands of the Unified Health System (Gcodes/SUS);
- Pharmaceutical Assistance Coordination (CAF);
- Health Surveillance Center of the Disease Control Coordination;
- Brazilian Medical Association;
- Paulista Association of Medicine;
- Federal Council of Medicine;
- Regional Council of Medicine;
- Brazilian Academy of Neurology – São Paulo Chapter;
- Paulista Society of Pediatrics;
- Society of Anesthesiology of the State of São Paulo;
- Brazilian Society of Psychiatry;
- Brazilian Society for the Study of Pain;
- Brazilian Society of Clinical Oncology;
- Society of Gastroenterology of the State of São Paulo;
- Brazilian Society of Internal Medicine;
- Brazilian Council of Ophthalmology;
- São Paulo Regional Council of Pharmacy;
- Faculty of Medicine of the University of São Paulo;
- Faculty of Medicine of Ribeirão Preto, University of São Paulo;
- Faculty of Medicine of Botucatu, São Paulo State University “Júlio de Mesquita Filho” (Unesp);
- Faculty of Medical Sciences of the University of Campinas (Unicamp);
- Paulista School of Medicine of the Federal University of São Paulo (Unifesp);
- Faculty of Medicine of Marília (Famema);
- Faculty of Medicine of São José do Rio Preto (Famerp);
- Faculty of Medicine of the University of São Carlos (Ufscar);
- Brazilian Bar Association (OAB);
- Public Ministry of the State of São Paulo (Mpesp);
- Court of Justice of São Paulo (TJSP);
- Legislative Assembly of the State of São Paulo (Alesp);
- National Health Surveillance Agency (Anvisa);
- Two representatives of organized civil society associations representing patients.
PRESENT LINK: Did you like this text? Subscriber can release five free hits of any link per day. Just click the blue F below.
[ad_2]
Source link
